Toward a Theranostic Role for Trop2 Immuno-PET
TO THE EDITOR: We read with great interest the recent article evaluating the novel trophoblast cell-surface antigen 2 (Trop2)–targeted tracer [18F]AlF-RESCA-RT4 for immuno-PET/CT imaging in breast cancer ([1][1]). One hour after tracer injection, uptake of the radiolabeled single-domain antibody
Authors
- François‐Clément Bidard (ORCID: https://orcid.org/0000-0001-5932-8949)
- Romain‐David Seban (ORCID: https://orcid.org/0000-0002-2584-5478)
- Irène Buvat (ORCID: https://orcid.org/0000-0002-7053-6471)
- Julien Fouque (ORCID: https://orcid.org/0000-0002-9914-8819)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2026-10-29
- DOI
- https://doi.org/10.2967/jnumed.126.273479
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00